Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 257 participants.
Also called NCT05238519
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose screening
- Phase
- Phase 3
- Enrolled
- 257 participants
- Sponsor
- Essentia Health
- Registry
-
NCT05238519
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05238519. Randomized; no masking; primary purpose screening. Start 2022-02-15 (actual); primary completion 2024-11-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)
- Acronym
- ID-FH
- Condition
- Familial Hypercholesterolemia
- Condition
- Cholesterol, Elevated
- Condition
- Genetic Disease
- Intervention (Behavioral)
- Motivational interview (MI)
- Lead sponsor
- Essentia Health
- Collaborator
- WHITESIDE Institute for Clinical Research
- Collaborator
- Aspirus St. Luke's Hospital
Record details
- Record id
cardio:ct-nct05238519- Content hash
905607ab85d592c5bad4eb7cdce2502b8ff5682f00f0a478ff19da69be62891e